|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2009-7-8
|
|
pubmed:abstractText |
In general, Indians have low HDL cholesterol levels. Fenofibrate, a drug widely used in the treatment of hypertriglyceridemia, usually also increases HDL cholesterol. There have been a few reports in the literature of a paradoxical decrease in serum HDL-cholesterol in patients treated with fenofibrate, either alone or in combination with a statin. We report three cases of paradoxical decrease in serum HDL-cholesterol in type 2 diabetic patients treated with a statin-fenofibrate combination.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0004-5772
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
57
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
180-1
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19582991-Cholesterol, HDL,
pubmed-meshheading:19582991-Diabetes Mellitus, Type 2,
pubmed-meshheading:19582991-Drug Therapy, Combination,
pubmed-meshheading:19582991-Dyslipidemias,
pubmed-meshheading:19582991-Fenofibrate,
pubmed-meshheading:19582991-Heptanoic Acids,
pubmed-meshheading:19582991-Humans,
pubmed-meshheading:19582991-Hypolipidemic Agents,
pubmed-meshheading:19582991-Male,
pubmed-meshheading:19582991-Middle Aged,
pubmed-meshheading:19582991-Pyrroles
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Unexpected and abnormally low HDL cholesterol levels on combination hypolipidemic therapy.
|
|
pubmed:affiliation |
Dr. Mohan's Diabetes Specialities Centre, & Madras Diabetes Research Foundation, WHO Collaborating Centre for Noncommunicable Diseases Prevention and Control, Chennai.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
